STOCK TITAN

Marblegate Capital (OTCQX: MGTE) holders approve 2026 equity plan and board

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Marblegate Capital Corporation reported results of its 2026 annual stockholder meeting held on June 11, 2026. Stockholders approved the Marblegate Capital Corporation 2026 Equity Incentive Plan, which authorizes 3,700,000 shares of common stock for awards such as options, stock appreciation rights, restricted stock, RSUs and performance awards, with an automatic annual increase of up to 3% of fully diluted shares from 2027 through 2030. Awards to non-employee directors are capped at $750,000 in grant-date value per year, rising to $1,000,000 in a director’s first year, and the plan runs for up to 10 years.

All five director nominees were elected to serve until the 2027 annual meeting. Stockholders also ratified Deloitte & Touche LLP as independent registered public accounting firm for the year ending December 31, 2026 and approved the potential adjournment/postponement of the meeting if additional proxies were needed. There were 73,914,402 shares outstanding as of the April 15, 2026 record date, and 69,848,939 shares (about 94.5%) were represented, establishing a strong quorum.

Positive

  • None.

Negative

  • None.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 5.07 Submission of Matters to a Vote of Security Holders Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Equity plan share reserve 3,700,000 shares Aggregate shares available under 2026 Equity Incentive Plan
Evergreen annual increase 3% of fully diluted shares Automatic annual increase from 2027 through 2030
Director award cap $750,000 per year Annual grant-date value limit for non-employee directors
Initial year director cap $1,000,000 Grant-date value limit in a director’s first fiscal year
Shares outstanding 73,914,402 shares Common stock outstanding as of April 15, 2026 record date
Shares represented at meeting 69,848,939 shares Shares present or represented at 2026 annual meeting (~94.5%)
Plan duration 10 years No awards after 10th anniversary of 2026 Plan effective date
Equity Incentive Plan financial
"the Marblegate Capital Corporation 2026 Equity Incentive Plan (the “2026 Plan”)"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
stock appreciation rights financial
"authorizes the grant of stock options, stock appreciation rights, restricted stock awards"
Stock appreciation rights (SARs) are a form of employee compensation that give the holder the right to receive the increase in a company's stock price over a set baseline, paid in cash or shares, without having to buy the stock. For investors, SARs matter because they can create future cash outflows or share dilution and signal how a company rewards and motivates executives — similar to giving a bonus tied directly to how well the company’s stock performs.
Evergreen Provision financial
"equal to the lesser of (A) three percent (3%)... (the “Evergreen Provision”)"
An evergreen provision is a clause in a financing or contract that automatically renews or replenishes the arrangement unless one party actively cancels it, like a subscription that keeps renewing each term. For investors it matters because it creates predictable, ongoing access to funding or ongoing contractual obligations — helping liquidity and planning — but can also hide long-term commitments or dilution risks if not reviewed.
independent registered public accounting firm financial
"as the Company’s independent registered public accounting firm for the year ending December 31, 2026"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
broker non-votes financial
"The results of the votes were as follows ... Broker Non-Votes"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false00019650520001965052us-gaap:CommonStockMember2026-06-112026-06-110001965052us-gaap:WarrantMember2026-06-112026-06-1100019650522026-06-112026-06-11

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 11, 2026

MARBLEGATE CAPITAL CORPORATION

(Exact name of registrant as specified in its charter)

 

Delaware

 

 

000-56734

 

92-2142791

(State or other jurisdiction

of incorporation)

 

 

Commission File Number

 

(I.R.S. Employer

Identification No.)

5 Greenwich Office Park, Suite 400

Greenwich, Connecticut

 

06831

(Address of principal executive offices)

 

(Zip Code)

Registrant’s telephone number, including area code: (203) 210-6500

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)*

Name of each exchange on which registered

N/A

MGTE

N/A

N/A

 

MGTEW

 

N/A

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

 


 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

*The registrant’s shares of common stock and warrants each trade over-the-counter on OTCQX® Best Market tier operated on the OTC Markets under the trading symbols “MGTE” and “MGTEW”, respectively.

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

As further described under Item 5.07 below, Marblegate Capital Corporation (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”) on June 11, 2026 at 10:00 am E.T. At the Annual Meeting, the Company’s stockholders approved the Marblegate Capital Corporation 2026 Equity Incentive Plan (the “2026 Plan”). The Company’s Board of Directors (the “Board”) previously approved the 2026 Plan, subject to receipt of stockholder approval at the Annual Meeting.

 

2026 Plan

 

The 2026 Plan authorizes the grant of stock options, stock appreciation rights, restricted stock awards, restricted stock units, performance awards, dividend equivalents and other stock- or cash-based awards. Employees, consultants and non-employee directors of the Company and its subsidiaries are eligible to receive awards under the 2026 Plan. Awards granted to non-employee directors are subject to an annual limit of $750,000 in aggregate grant-date value (increased to $1,000,000 in the fiscal year of a director’s initial service). Subject to adjustment for certain corporate transactions, the aggregate number of shares of common stock, par value $0.0001 per share (the “Common Stock”), available for issuance under the 2026 Plan is the sum of (i) 3,700,000 shares, and (ii) an automatic annual increase on the first day of each year beginning in 2027 and ending in (and including) 2030 equal to the lesser of (A) three percent (3%) of the shares outstanding on a fully diluted basis on the last day of the immediately preceding fiscal year, and (B) such smaller number of shares of Common Stock as determined by the Board or the compensation committee (the “Evergreen Provision”). Notwithstanding the foregoing, the aggregate maximum number of shares that may be issued pursuant to the exercise of incentive stock options is 3,700,000 shares.

 

The 2026 Plan will be administered by the Board or the compensation committee of the Board, which will have authority to determine the participants, types of awards granted, vesting schedules, performance criteria and other terms and conditions of awards. Awards may be settled in shares of Common Stock, cash or a combination thereof.

 

The 2026 Plan contains customary anti-dilution adjustment provisions applicable in the event of stock splits, recapitalizations, reorganizations and similar transactions. The Board may amend or terminate the 2026 Plan at any time, provided that stockholder approval is required to increase the aggregate share reserve (except pursuant to the Evergreen Provision) and for any repricing of options or stock appreciation rights, and as otherwise required by applicable law or stock exchange rules. No amendment, suspension or termination may materially and adversely affect a previously granted award without the holder’s consent, subject to the terms of the 2026 Plan. No awards may be granted under the 2026 Plan after the 10th anniversary of the 2026 Plan’s effective date (and no incentive stock options may be granted after the 10th anniversary of the Board’s adoption of the 2026 Plan).

 

This summary of the 2026 Plan is not complete and is qualified in its entirety by reference to the full text of the 2026 Plan, which is filed as Exhibit 10.1 to this report and is incorporated herein by reference.

 

 

Item 5.07. Submission of Matters to a Vote of Security Holders.

On June 11, 2026, the Company held the Annual Meeting. In connection with the Annual Meeting, proxies were solicited pursuant to the Securities Exchange Act of 1934, as amended. At the close of business on April 15, 2026, the record date for the Annual Meeting (the “Record Date”), there were 73,914,402 shares of Common Stock issued and outstanding, which constituted all of the issued and outstanding capital stock of the Company as of the Record Date.

 

 


 

At the Annual Meeting, 69,848,939 of the Company’s 73,914,402 outstanding shares of Common Stock entitled to vote as of the Record Date, or approximately 94.5%, were represented by proxy or in person (virtually), and, therefore, a quorum was present. The following are the voting results for the items of business considered and voted upon at the Annual Meeting, all of which were described in the Company’s Notice of 2026 Annual Meeting of Stockholders and 2026 Proxy Statement, filed with the Securities and Exchange Commission on April 29, 2026, as supplemented.

 

The following matters were submitted to the Company’s stockholders:

 

Proposal 1: Election of Directors

 

The stockholders elected each of the Company’s five director nominees, each to serve until the 2027 annual meeting of stockholders and thereafter until their successors are elected and qualified (the “Board Proposal”). The results of the votes were as follows:

Proposal

Votes For All

Withheld All

Broker
Non-Votes

Harvey Golub

68,388,143

225,000

1,235,796

Sarah E. Feinberg

68,163,143

450,000

1,235,796

 

Frederick C. Herbst

68,613,143

0

1,235,796

Meera Joshi

68,613,143

0

1,235,796

 

Andrew Milgram

68,601,894

11,249

1,235,796

 

 

Proposal 2: Approval and Adoption of the 2026 Plan

 

The stockholders approved and adopted the 2026 Plan (the “Equity Plan Proposal”). The results of the votes were as follows:

 

Proposal

Votes For

Votes
Against

 

Abstentions

Broker
Non-Votes

Approval and adoption of the 2026 Plan

 

292,663

845

1,235,796

 

 

Proposal 3: Ratification of Independent Registered Public Accounting Firm

 

The stockholders ratified the appointment of Deloitte & Touche LLP by the audit committee of the Board as the Company’s independent registered public accounting firm for the year ending December 31, 2026 (the “Auditor Proposal”). The results of the votes were as follows:

 

Proposal

Votes For

Votes
Against

 

Abstentions

Ratification of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026

 

23,575

250

 

 

Proposal 4: Approval of Adjournment or Postponement

 

The stockholders approved the adjournment or postponement of the annual meeting, if necessary, to solicit additional proxies, if there were not sufficient votes in favor of the Board Proposal, the Equity Plan Proposal, or the Auditor Proposal. The results of the votes were as follows:

 

 


 

Proposal

Votes For

Votes
Against

 

Abstentions

Approval of an adjournment or postponement of the meeting, if necessary, to solicit additional proxies, if there are not sufficient votes in favor of the Board Proposal, Equity Plan Proposal or Auditor Proposal

 

261,416

1,007

 

 

Item 9.01

Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.

Description

10.1+

 

Marblegate Capital Corporation 2026 Equity Incentive Plan.

 

 

 

104

Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

+Indicates a management contract or a compensatory plan, contract or arrangement.

 

 

 


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: June 12, 2026

MARBLEGATE CAPITAL CORPORATION

By:

/s/ Michael Hutchby

Name:

Michael Hutchby

Title:

Chief Financial Officer

2

 


FAQ

What did Marblegate Capital (MGTE) stockholders approve at the 2026 annual meeting?

Stockholders approved the 2026 Equity Incentive Plan, re-elected five directors, ratified Deloitte & Touche LLP as auditor, and authorized potential adjournment or postponement of the meeting. These actions confirm board leadership, compensation structure, and the external auditor for 2026.

How large is Marblegate Capital’s 2026 Equity Incentive Plan?

The 2026 Equity Incentive Plan initially covers 3,700,000 shares of common stock. It also includes an automatic annual increase of up to 3% of fully diluted shares from 2027 through 2030, subject to board or compensation committee decisions each year.

Who is eligible to receive awards under Marblegate (MGTE) 2026 Equity Incentive Plan?

Employees, consultants and non-employee directors of Marblegate Capital Corporation and its subsidiaries are eligible. Awards can include stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, dividend equivalents, and other stock- or cash-based incentives.

What limits apply to non-employee director awards under MGTE’s 2026 Plan?

Awards to any non-employee director are capped at $750,000 in aggregate grant-date value per fiscal year, increasing to $1,000,000 in the fiscal year of that director’s initial service. These limits are designed to constrain overall equity and cash compensation per director.

How long will Marblegate’s 2026 Equity Incentive Plan remain in effect?

No awards may be granted under the 2026 Plan after the 10th anniversary of its effective date. Incentive stock options specifically cannot be granted after the 10th anniversary of the board’s adoption, aligning the plan with typical long-term compensation horizons.

What was Marblegate Capital’s shareholder turnout at the 2026 annual meeting?

There were 73,914,402 shares of common stock outstanding as of the April 15, 2026 record date. At the meeting, 69,848,939 shares, or approximately 94.5% of eligible shares, were represented by proxy or in person, providing a strong quorum for voting.

Filing Exhibits & Attachments

1 document